July 31, 2022 Comments Off on New patent expiration for Padagis Us drug EVAMIST Posted in: Uncategorized
Annual Drug Patent Expirations for EVAMIST Evamist is a drug marketed by Padagis Us and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Padagis Us drug EVAMIST appeared first on DrugPat…
July 31, 2022 Comments Off on Drug Patent Expirations for the Week of July 31, 2022 Posted in: Uncategorized
MACRILEN (macimorelin acetate) Novo Patent: 6,861,409 Expiration: Aug 1, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pate…
